Nimbex and Pancuronium bromide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nimbex (cisatracurium besylate) and Pancuronium bromide (pancuronium bromide). Common drug interactions include amnesia among females and propofol infusion syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Nimbex and Pancuronium bromide. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Nimbex?

Nimbex has active ingredients of cisatracurium besylate. eHealthMe is studying from 1,546 Nimbex users. Check the latest studies of Nimbex.

What is Pancuronium bromide?

Pancuronium bromide has active ingredients of pancuronium bromide. eHealthMe is studying from 666 Pancuronium bromide users. Check the latest studies of Pancuronium bromide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

13 people who take Nimbex and Pancuronium bromide together, and have interactions are studied.

Nimbex and Pancuronium bromide drug interactions.

What are the common drug interactions of Nimbex and Pancuronium Bromide, by gender? *:

female:

Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Anxiety
Cardiac disorder
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Depression
Emotional distress
Fear
Hallucination, visual (seeing things that aren't there)
Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
Pain

male:

Propofol infusion syndrome
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Multi-organ failure (multisystem organ failure)
Oliguria (not enough urine)
Pain
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Renal injury (kidney injury)
Stress
Cardiac disorder

What are the common drug interactions of Nimbex and Pancuronium Bromide, by age (0-1 to 60+)? *:

0-1:

Drug ineffective

2-9:

n/a

10-19:

n/a

20-29:

Propofol infusion syndrome
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Renal failure acute (rapid kidney dysfunction)
Oliguria (not enough urine)

30-39:

n/a

40-49:

Cardiac disorder
Cardiac failure congestive
Cardiomyopathy (weakening of the heart muscle)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Hypercholesterolaemia (high levels of cholesterol in the blood)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Propofol infusion syndrome
Pulmonary hypertension (increase in blood pressure in the lung artery)
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)

50-59:

Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Anxiety
Collapse of lung (functional breakdown of lung)
Injury
Multi-organ failure (multisystem organ failure)
Cardiac disorder
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Depression
Hallucination, visual (seeing things that aren't there)
Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)

60+:

n/a

What are the existing conditions these people have? *

Sedation: 9 people, 69.23%
Aspergillosis (an infection caused by a fungus called aspergillus): 3 people, 23.08%
Pneumonia: 1 person, 7.69%
Diabetes: 1 person, 7.69%
Acute Severe Asthma: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Nimbex and Pancuronium bromide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously